Chesnara Plc: Fourth acquisition in two years
12 November 2026
Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a major player in the global pharmaceutical industry, presents an intriguing opportunity for investors with its potential 6.97% upside. Headquartered..
Moderna, Inc. (NASDAQ: MRNA), the biotechnology powerhouse known for its pioneering work in messenger RNA (mRNA) medicines, finds itself at a critical juncture. With a current..
Option Care Health, Inc. (NASDAQ: OPCH) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..
Fresenius Medical Care AG (NYSE: FMS), a leading player in the healthcare sector, particularly in medical care facilities, stands out with a promising potential upside of..
Medtronic plc (NYSE: MDT), a leader in the medical devices industry, is headquartered in Galway, Ireland, and operates across the globe, offering innovative healthcare solutions. With..
Cencora, Inc. (NYSE: COR), a leading player in the healthcare sector, has caught the attention of savvy investors with its robust market presence and promising growth..
Telix Pharmaceuticals Limited (ASX: TLX) is capturing the attention of investors with its impressive 101.98% potential upside, as calculated from its current price of $10.54 USD..
TG Therapeutics, Inc. (NASDAQ: TGTX) is generating buzz in the biotech investment community, buoyed by a promising 31.72% potential upside, according to analyst ratings. Positioned in..
iRhythm Holdings, Inc. (NASDAQ: IRTC), a prominent player in the healthcare sector, is garnering significant attention from investors, particularly within the medical devices industry. The San..
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading player in the biotechnology industry, stands out with a potential upside of 62.97%, making it an attractive consideration for..
Cardinal Health, Inc. (NYSE: CAH) is making waves in the healthcare sector with its robust market presence and promising growth potential. Currently valued at $50.72 billion,..
Prestige Consumer Healthcare Inc. (NYSE: PBH) is capturing investor attention with its compelling upside potential of nearly 39%, as indicated by analysts’ average target price of..
Lantheus Holdings, Inc. (NASDAQ: LNTH) is garnering attention from investors due to its promising potential in the healthcare sector. Specializing in diagnostic and therapeutic products for..
Neurocrine Biosciences, Inc. (NBIX), a healthcare entity specializing in the development and commercialization of pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders, presents an intriguing opportunity..
BridgeBio Pharma, Inc. (NASDAQ: BBIO), a prominent player in the biotechnology sector, is capturing attention with its robust portfolio dedicated to treating genetic diseases. The company’s..
Pfizer, Inc. (NYSE: PFE), a heavyweight in the healthcare sector, is a stalwart in the drug manufacturing industry, offering a wide array of biopharmaceutical products globally...
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is drawing attention from investors, not only for its innovative strides in RNA-targeted medicines but also for the compelling 29.84% potential..
For investors with a keen eye on the healthcare sector, Glaukos Corporation (NYSE: GKOS) presents an intriguing opportunity. As a prominent player in the medical devices..
